Osteoarthritis treatment: Is it finally time to consider glucosamine seriously?

Affiliations

Editorial

Jean-Pierre Raynauld. Int J Rheum Dis. 2019 Mar.

. 2019 Mar;22(3):338-339.

doi: 10.1111/1756-185X.13522.

¹ Rheumatologist and Head of Osteoarthritis Clinical Research, Montreal Rheumatology Institute, University of Montreal, Montreal, Quebec, Canada.

No abstract available

Comment on

Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment.
Saengnipanthkul S, Waikakul S, Rojanasthien S, Totemchokchyakarn K, Srinkapaibulaya A, Cheh Chin T, Mai Hong N, Bruyère O, Cooper C, Reginster JY, Lwin M. Saengnipanthkul S, et al. Int J Rheum Dis. 2019 Mar;22(3):376-385. doi: 10.1111/1756-185X.13068. Epub 2017 Mar 23. Int J Rheum Dis. 2019. PMID: 28332780 Review.